Ian M. Burr Division of Pediatric Endocrinology and Diabetes Archive — Page 3 of 3

A girl undergoes an eye screening with a tabletop retinal imaging device while a staff member stands beside the equipment.
January 14, 2016

New tool in fight against pediatric diabetic retinopathy

The Children’s Diabetes Program at Monroe Carell Jr. Children’s Hospital at Vanderbilt recently unveiled its latest tool in helping to prevent diabetic retinopathy, the leading cause of acquired blindness in the United States.

By Jessica Pasley
conceptual - glowing cell
October 1, 2015

Tolerating a transplant

A new genetic model has generated new strategies for promoting tolerance to transplants – and improving long-term transplant outcomes – in the background of autoimmune disease.

By Leigh MacMillan
Insulin in vials
September 10, 2015

Diabetes trial targets body’s ability to produce insulin

Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment.

By Vanderbilt Health News
Smiling woman with shoulder-length brown hair wearing a light green blouse and necklace, standing in a bright interior with a staircase in the background.
August 13, 2015

Simmons strives to make a difference in children’s lives

Jill Simmons, M.D., encounters medical mysteries that have the makings of a science fiction film or novel.

By Christina Echegaray
Three jockeys race horses across a steeplechase course, with spectators gathered behind a wooden fence.
April 9, 2015

Steeplechase again set to saddle up for Children’s Hospital

Nashville and Monroe Carell Jr. Children’s Hospital at Vanderbilt are gearing up for another year of one of America’s premier horse racing events, the Iroquois Steeplechase, now in its 74th year.

By Christina Echegaray
Close-up of a hand with a fingertip blood drop held near a blue blood glucose meter displaying a numeric reading.
September 12, 2013

VU tracking drug’s ability to prevent type 1 diabetes

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

By Vanderbilt Health News